P-17 (Digna/Flamel)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameP-17 (Digna/Flamel)
Drug Alias NameP-17
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsAngiogenesis disorderLiver CirrhosisNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDigna Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderLiver CirrhosisNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A